Cell-cultured milk from Canada’s Opalia could be ready for market by 2024 following recent production benchmarks. And as the demand for dairy alternatives continues to accelerate, brands like Perfect Day have laid a lot of the groundwork, setting Opalia up for success.
Following the achievement of “functional complexity,” Opalia, formerly known as BetterMilk Inc., says it’s ready to start pre-pilot scale production of its cell-based milk for use in non-animal dairy products. The Cult Food Science Corp. portfolio company says it has successfully replaced fetal bovine serum (FBS) which has helped to reduce costs and make market viability a reality, pending regulatory approval.
“We are 100-percent focused on manufacturing a dairy product that negates any potential harm to animals and eliminates the massive environmental impact of traditional dairy products and production, therefore the breakthrough replacement of FBS for Opalia’s products is exciting”, Jennifer Cote, Chief Executive Officer of Opalia, said in a statement. “We are excited to be one step closer to upscaling production of our cell-based milk and to engage with downstream partners that are interested in commercialization of our milk.”
Read more here: https://rfr.bz/l4i5ndw
Opalia is a part of BIV’s New Protein Fund I portfolio. If you would like to join our community of change-makers and receive a US$200,000 investment package to fast-track your alternative protein startup apply on our website 👉 https://rfr.bz/l4gju4l